جميع الدراسات
التوظيفرَصْدِيّ

Observational Study of Adults and Adolescents With Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP)

This study aims to understand more about Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP) in people aged 12 and older. It's an observational study, which means participants won't receive a new treatment or medication. Instead, researchers will gather information about how these conditions affect daily life and health. This will involve regular visits over six months to check symptoms, take blood samples, measure vital signs, and possibly wear a device to track light exposure. Participants will also keep a daily diary of their symptoms. The goal is to collect important data that could help improve our understanding and care for people with EPP and XLP.

نظرة سريعة

الحالة
التوظيف
الراعي
Portal Therapeutics, Inc.
الهدف من التسجيل
50
ابدأ
30 أبريل 2026
التاريخ المتوقع للانتهاء
01 أبريل 2027

ما هو موضوع هذه الدراسة؟

This study focuses on two rare conditions called Erythropoietic Protoporphyria (EPP) and X-linked Porphyria (XLP). If you or someone you know has been diagnosed with one of these conditions, you might be familiar with the challenges they can bring, especially related to sun exposure. The main purpose of this research is to collect detailed information about how these conditions affect adults and teenagers in their everyday lives.

It's important to know that this isn't a study where you'll try a new medicine or treatment. Instead, it's an 'observational' study. This means the researchers will simply observe and record information about your condition as it is, without changing your current care. By carefully collecting these details from many people, scientists can gain a much clearer picture of EPP and XLP.

The information gathered will help doctors and researchers understand the conditions better, which could eventually lead to improved ways to diagnose, manage, and care for people living with EPP and XLP in the future. Your participation could make a real difference in advancing our knowledge.

النقاط الرئيسية

  • Study collects information on EPP/XLP in ages 12 and up.
  • إنها دراسة ملاحظة؛ لا تُعطى علاجات جديدة.
  • Participation involves periodic visits and symptom diaries over 6 months.
  • Helps researchers understand EPP/XLP better, potentially improving future care.
  • يمكنك الانسحاب من الدراسة في أي وقت.

من قد يكون مؤهلاً؟

To join this study, you need to be at least 12 years old and have a confirmed diagnosis of EPP or XLP. This diagnosis might be based on genetic tests showing specific changes in your genes, or on blood tests that show high levels of a substance called PPIX, along with your symptoms and family history.

You should currently be experiencing symptoms of EPP or XLP. A key part of this is having a history of feeling a consistent, non-painful sensation within about 45 minutes of sun exposure, just before you experience more severe skin reactions. You also need to be willing to participate fully, which includes wearing a special device that measures light, keeping a daily diary of your symptoms, and covering certain areas of your skin when asked for specific tests.

هل يمكن أن تناسبك هذه الدراسة؟

أجب عن هذه الأسئلة السريعة لترى ما إذا كنت مؤهلاً. هذا دليل فقط - الفريق البحثي هو الذي يتخذ القرار النهائي.

  1. هل عمرك 12 سنة أو أكثر؟
  2. Do you have a confirmed diagnosis of EPP or XLP?
  3. Are you currently experiencing symptoms related to EPP/XLP?
  4. Do you have a history of feeling early, mild symptoms before sun-related skin reactions?
  5. Are you willing to wear a light-measuring device and keep a daily symptom diary?
أجب عن كل سؤال لترى نتيجتك.

ماذا يتضمن المشاركة؟

If you decide to take part, the study will last for up to 6 months. After an initial screening, you'll have a first main visit (called Baseline Day 1). Over the next 24 weeks, you'll come back for follow-up visits every 4 weeks.

During these visits and at home, you'll be asked to do several things. This includes having standard checks like physical exams, measuring your blood pressure and heart rate (vital signs), and giving blood samples to check certain levels in your blood. You might also be asked to wear a device that measures the amount of light you're exposed to. A very important part of the study is keeping a daily diary to record your EPP/XLP-related symptoms. It's also possible you may need to keep certain skin areas covered before specific tests, as explained by the study team. You won't receive any new treatments as part of this study.

المخاطر والفوائد المحتملة

Participating in this study might not directly benefit your health immediately, as it doesn't involve new treatments. However, the information gathered could significantly help future patients by improving our overall understanding of EPP and XLP. Potential risks are generally low, mainly involving the inconvenience of regular visits, blood draws which can cause minor bruising or discomfort, and the time commitment for daily diary entries. You are free to withdraw from the study at any time, for any reason, without it affecting your medical care.

Locations (19)

  • مستشفى ماساتشوستس العام
    الرمز البريدي المؤكد
    بوسطن، الولايات المتحدة· التوظيف
  • Mount Sinai School of Medicine
    الرمز البريدي المؤكد
    نيويورك، الولايات المتحدة· التوظيف
  • Wake Forest University Baptist Health - Dept of Gastroenterology
    الرمز البريدي المؤكد
    Wake Forest, United States· التوظيف
  • Temple University
    الرمز البريدي المؤكد
    فيلادلفيا، الولايات المتحدة· لم يبدأ التوظيف بعد
  • University of Texas Health - Ertan Digestive Disease Center
    الرمز البريدي المؤكد
    هيوستن، الولايات المتحدة· التوظيف
  • مستشفى جامعة لوفين
    الرمز البريدي المؤكد
    لوفين، بلجيكا· لم يبدأ التوظيف بعد
  • University of Alberta Hospital
    الرمز البريدي المؤكد
    إدمونتون، كندا· لم يبدأ التوظيف بعد
  • Centre Hospitalier Universitaire de Bordeaux - Hopital Saint - Andre
    الرمز البريدي المؤكد
    بوردو، فرنسا· لم يبدأ التوظيف بعد
  • AP-HP Hopital Bichat - Claude Bernard
    الرمز البريدي المؤكد
    باريس، فرنسا· لم يبدأ التوظيف بعد
  • Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico di Milano
    الرمز البريدي المؤكد
    ميلانو، إيطاليا· لم يبدأ التوظيف بعد
  • Azienda Ospedaliero-Universitaria di Modena
    الرمز البريدي المؤكد
    Modena, Italy· لم يبدأ التوظيف بعد
  • Haukeland University Hospital
    الرمز البريدي المؤكد
    Bergen, Norway· لم يبدأ التوظيف بعد

أسئلة شائعة

What is an 'observational' study?

An observational study means researchers watch and collect information about your condition without giving you any new treatments or medicines. They just observe what is already happening.

هل سأحصل على دواء جديد في هذه الدراسة؟

No, this study is about collecting information only. You will not be given any new treatments or medications as part of your participation.

كم من الوقت سأحتاج للبقاء في الدراسة؟

The study will last for up to 6 months for each person who takes part.

ما نوع الاختبارات التي سأخضع لها؟

You'll have physical exams, blood tests, your vital signs (like blood pressure) checked, and you'll complete a daily diary. You might also wear a device that measures light.

هل يمكنني مغادرة الدراسة إذا غيرت رأيي؟

Yes, you can decide to leave the study at any time, for any reason. It will not affect your usual medical care.

كيفية معرفة المزيد

GondolaBio Inquiries

تحدث دائمًا إلى طبيبك العام أو الأخصائي قبل اتخاذ قرار بالمشاركة في دراسة.

هل أنت مهتم بالمشاركة؟

سجل اهتمامك

شارك تفاصيلك وفريق البحث لـ "Observational Study of Adults and Adolescents With Erythropo… "سيتواصل معك إذا كنت مؤهلاً. تحدث دائمًا إلى طبيبك قبل الموافقة على المشاركة.

نقاش

مناقشة المجتمع

مدعوم من منتدانا في community.patient.info. يرجى التحلي بالاحترام — هذه ليست نصيحة طبية.